Vita Life Sciences (ASX:VLS) Debt-to-Asset

: 0.01 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Vita Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.21 Mil. Vita Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.18 Mil. Vita Life Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was A$59.81 Mil. Vita Life Sciences's debt to asset for the quarter that ended in Dec. 2023 was 0.01.

Vita Life Sciences Debt-to-Asset Historical Data

The historical data trend for Vita Life Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.06

0.05

0.01

Vita Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Asset																0.01	0.01	0.01	0.01	0.01

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vita Life Sciences Debt-to-Asset Distribution

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's Debt-to-Asset falls into.

Vita Life Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Vita Life Sciences's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.211	+	0.176)	/	59.807
	=	0.01

Vita Life Sciences's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.211	+	0.176)	/	59.807
	=	0.01

Vita Life Sciences (ASX:VLS) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Vita Life Sciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Vita Life Sciences (ASX:VLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232

Website

https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region.

Vita Life Sciences (ASX:VLS) Headlines

No Headlines